78014 includes thyroid uptake measurement with the imaging; 78013 represents imaging with blood-flow assessment without that uptake measurement.
On this page
CMS RVU26D · Effective 2026-10-01
78013 Thyroid imaging Medicare reimbursement rates in Arkansas
Reports nuclear medicine imaging of the thyroid that includes blood-flow assessment, used to evaluate thyroid tissue distribution and suspected functional abnormalities. Compare 78013 office and facility rates across CMS payment localities in Arkansas.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 78013 in Arkansas?
Arkansas has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$143.72
1 of 1 localities have a supported rate.
Payment area: Arkansas
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Nuclear medicine
About 78013: Thyroid imaging with blood-flow assessment
Reports nuclear medicine imaging of the thyroid that includes blood-flow assessment, used to evaluate thyroid tissue distribution and suspected functional abnormalities.
A nuclear medicine study captures images of the thyroid and includes a blood-flow phase. It can help evaluate the distribution of functioning thyroid tissue, including suspected autonomous tissue or ectopic thyroid tissue. A nuclear medicine physician or radiologist typically interprets the images after acquisition with a gamma camera in a hospital or imaging center.
Report 78013 when the service includes thyroid imaging with blood-flow assessment but does not include quantitative thyroid uptake measurement. The record should support the clinical reason for imaging and document the performed imaging protocol and interpretation. CMS recognizes a professional component for interpretation, reported with modifier 26, and a technical component for equipment and staff, reported with modifier TC. Without either modifier, the claim represents the global service.
CMS billing rules for 78013
- Professional and technical components
- Diagnostic test with a professional component (modifier 26, interpretation) and a technical component (modifier TC, equipment and staff); billing without a modifier is the global service.
Where the value comes from
- Work RVU0.36 · 7%
- Practice expense (office) RVU4.56 · 92%
- Malpractice RVU0.05 · 1%
695
Medicare services in 2024 · #3271 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
78013 compared with similar codes
Office rates for Arkansas, from the same CMS release.
78012 reports quantitative thyroid uptake measurement alone. Choose 78013 when thyroid imaging with blood-flow assessment is performed instead.
78015 is directed at imaging thyroid carcinoma metastases in a limited area, not imaging the thyroid gland with blood-flow assessment.
Compare 78013 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Arkansas →
Office / nonfacility
$143.72
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 78013 in Arkansas.
PPRRVU2026_Oct_nonQPP.csv
9,182
- Code
- 78013
- Physician work
- 0.36
- Practice expense
- 4.56
- Malpractice
- 0.05
GPCI2026.csv
7
- Locality
- Arkansas
- Physician work
- 1.000
- Practice expense
- 0.859
- Malpractice
- 0.515
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.36 | × 1.000 | 0.3600 |
| Practice expense | 4.56 | × 0.859 | 3.9170 |
| Malpractice | 0.05 | × 0.515 | 0.0258 |
| Total RVUs | 4.3028 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Arkansas$143.72
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0.36 | 1 |
| Practice expense | 4.56 | 0.859 |
| Malpractice | 0.05 | 0.515 |
(0.36 × 1 + 4.56 × 0.859 + 0.05 × 0.515) × $33.4009 = $143.72
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
78013 billing questions
How does 78013 differ from 78014?
78013 represents thyroid imaging with blood-flow assessment. Use 78014 when the imaging service also includes one or more quantitative thyroid uptake measurements.
When should 78012 be considered instead?
78012 is for quantitative thyroid uptake measurement without the thyroid imaging service represented by 78013. Choose based on the service actually performed and documented.
When are modifiers 26 and TC appropriate?
Use modifier 26 for the physician's interpretation and modifier TC for the technical service, including equipment and staff. Billing without either modifier represents the global service.
What documentation supports reporting 78013?
Document the clinical reason for the thyroid study, the imaging performed including its blood-flow phase, and the physician's interpretation. The record should distinguish imaging from any separately performed uptake measurement.
Is 78013 the code for thyroid cancer metastasis imaging?
No. 78013 describes thyroid imaging with blood-flow assessment; 78015 is for imaging directed at thyroid carcinoma metastases in a limited area.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
